Suppr超能文献

原发性醛固酮增多症中醛固酮:肾素比值的患者内可重复性。

Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism.

机构信息

DMCS-Internal Medicine 4, University Hospital, Via Giustiniani 2, 35126 Padova, Italy.

出版信息

Hypertension. 2010 Jan;55(1):83-9. doi: 10.1161/HYPERTENSIONAHA.109.139832. Epub 2009 Nov 23.

Abstract

The plasma aldosterone concentration:renin ratio (ARR) is widely used for the screening of primary aldosteronism, but its reproducibility is unknown. We, therefore, investigated the within-patient reproducibility of the ARR in a prospective multicenter study of consecutive hypertensive patients referred to specialized centers for hypertension in Italy. After the patients were carefully prepared from the pharmacological standpoint, the ARR was determined at baseline in 1136 patients and repeated after, on average, 4 weeks in the patients who had initially an ARR > or =40 and in 1 of every 4 of those with an ARR <40. The reproducibility of the ARR was assessed with Passing and Bablok and Deming regression, coefficient of reproducibility, and Bland-Altman and Mountain plots. Within-patient ARR comparison was available in 268 patients, of whom 49 had an aldosterone-producing adenoma, on the basis of the "4-corner criteria." The ARR showed a highly significant within-patient correlation (r=0.69; P<0.0001) and reproducibility. Bland-Altman plot showed no proportional, magnitude-related, or absolute systematic error between the ARR; moreover, only 7% of the values, for example, slightly more than what could be expected by chance, fell out of the 95% CI for the between-test difference. The accuracy of each ARR for pinpointing aldosterone-producing adenoma patients was approximately 80%. Thus, although it was performed under different conditions in a multicenter study, the ARR showed a good within-patient reproducibility. Hence, contrary to previously claimed poor reproducibility of the ARR, these data support its use for the screening of primary aldosteronism.

摘要

血浆醛固酮浓度

肾素比值(ARR)广泛用于原发性醛固酮增多症的筛查,但尚不清楚其可重复性。因此,我们在意大利专门的高血压中心对连续高血压患者进行了前瞻性多中心研究,以调查 ARR 的患者内可重复性。在从药理学角度仔细准备患者后,在 1136 例患者中确定了 ARR 的基线值,并在最初 ARR≥40 的患者中平均 4 周后重复测量,在 ARR<40 的患者中每 4 例中重复测量 1 例。ARR 的可重复性采用 Passing 和 Bablok 以及 Deming 回归、重复性系数、Bland-Altman 和 Mountain 图进行评估。在 268 例患者中可进行患者内 ARR 比较,其中 49 例基于“四角标准”患有醛固酮分泌瘤。ARR 显示出高度显著的患者内相关性(r=0.69;P<0.0001)和可重复性。Bland-Altman 图显示 ARR 之间没有比例、大小相关或绝对系统误差;此外,只有 7%的数值,例如略高于可能出现的随机值,超出了两次测试差异的 95%置信区间。ARR 确定醛固酮分泌瘤患者的准确性约为 80%。因此,尽管在多中心研究中在不同条件下进行,但 ARR 显示出良好的患者内可重复性。因此,与之前声称的 ARR 可重复性差相反,这些数据支持其用于原发性醛固酮增多症的筛查。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验